You are here

diabetes

ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study

Fierce Pharma

Mon, 06/25/18 - 09:07 pm

Is Eversense the Latest Game Changer in the Diabetes Market?

Medical Devices and Diagnostics Industry

Sun, 06/24/18 - 09:34 pm

blood glucose monitoring

Novo reveals more Ozempic data on change in body weight by baseline BMI

Yahoo/Reuters

Sat, 06/23/18 - 01:08 pm

Drug Pricing Turns to Insulin As Politicians, AMA And Docs Look to Pharma

TheStreet.com

Sat, 06/23/18 - 01:06 pm

Big News Sends Tandem Diabetes Soaring 10.2% Today

Motley Fool

Fri, 06/22/18 - 07:56 pm

glucose monitoring

Tandem Diabetes

Omada Health launches new programs for obesity-related diseases

Healthcare Dive

Fri, 06/22/18 - 07:52 pm

digital therapeutics

FDA Approves First Glucose Monitoring System with Fully Implantable Sensor

Fri, 06/22/18 - 10:29 am

Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia

Fierce Pharma

Thu, 06/21/18 - 10:58 pm

Controversial researcher’s diabetes vaccine causes improvement in small study

Stat

Thu, 06/21/18 - 10:11 am

type 1 diabetes

clinical trials

Organon Teknika

Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs

Yahoo/Zacks.com

Wed, 06/20/18 - 10:20 pm

Study finds nearly half of people with diabetes skip care due to costs

Drug Delivery Business News

Mon, 06/18/18 - 09:48 pm

Novo Nordisk's oral diabetes drug beats Jardiance in study

Yahoo/Reuters

Tue, 05/29/18 - 11:07 pm

[video+transcript] 2 Giant Medical Device Companies Transforming Diabetes

Motley Fool

Mon, 05/28/18 - 01:45 pm

Brain’s role in diabetes: new approach to insulin regulation

GoinPharma

Fri, 05/25/18 - 09:51 am

Valeritas touts new data for insulin delivery device

Drug Delivery Business News

Fri, 05/18/18 - 12:27 pm

insulin delivery

This tiny chip uses A.I. to control blood sugar levels for critical diabetes patients

CNBC

Fri, 05/11/18 - 10:01 pm

artificial intelligence

Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback

Endpoints

Thu, 05/10/18 - 11:02 pm

Novo Nordisk results show GLP-1s are job 1. Can its crucial Ozempic launch deliver?

Fierce Pharma

Wed, 05/2/18 - 07:24 pm

Novo Nordisk tackles outcomes and affordability with pilot tying copays to adherence

Fierce Pharma

Wed, 04/18/18 - 11:07 pm

outcomes-based pricing

AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval

Drug Delivery Business News

Tue, 04/3/18 - 10:52 pm

Pages